We break down industry position, business model, moat and financial quality first — then return to valuation, positioning and trade structure. Conclusions change; the framework must stay inspectable, and survive both the bull and the bear case.
We break down industry position, business model, moat and financial quality first — then return to valuation, positioning and trade structure. Conclusions change; the framework must stay inspectable, and survive both the bull and the bear case.
From single companies to portfolios, macro forces and multi-case series — pick the scale that fits the question.
Business, financials, competitive advantage and risk scenarios.
ETFs, factors, tax and portfolio structure.
Rates, policy, geopolitics and their transmission paths.
Compare multiple cases of the same theme side by side.
The three most recent pieces — start from the newest view.
Robotics, AI, cyber, uranium, infrastructure — five thematic ETFs pass the screen, but URA is annualized at -2.55% over 15 years and BOTZ still lags the market even with a real Nvidia bet baked in. The theme playing out doesn't mean you got paid — three variables sit in between.
Biotech is a portfolio of binary events: FDA approval is the gate, and the PDUFA date is when the lottery is drawn. XBI equal-weights a bet on broad innovation; IBB cap-weights a bet on incumbent leaders. Neither logic is wrong — you're choosing which bet to make.
Revenue up 36% YoY, full-year guidance raised again — and the stock still dropped nearly 20% in a day on one AI-native customer's usage pullback. 750+ AI-native customers, non-AI revenue growth accelerating toward 30%, and four distinct AI/MCP product lines (LLM Observability, Agent Observability, Datadog MCP Server, Bits AI): concentration is being diluted, just not fast enough this quarter.
Start from the first article of each series and build the framework in order.
Mergers and spin-offs are two sides of the same capital allocation question. This introduction uses conglomerate discount, focus premium and the best owner test to judge when to merge and when to split.
Most M&A failures aren't valuation mistakes — they're people mistakes. This opening piece maps five M&A archetypes around one question: after the deal closes, do you trust the people you acquired, or do you control them? A strategic framework for Taiwan enterprises going global.
BDCs are legally mandated to distribute 90% of taxable income as dividends — yielding 9–13% annually. This guide breaks down the structure, income mechanics, six key risks, and practical steps for Taiwan-based investors.